{
  "docId": "019de075-881d-736b-8f07-b074ed7dfeb5",
  "docSlug": "6a57ccf571f205aca9c4c1050696b3ed",
  "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 39,
  "pageCount": 43,
  "prevPage": 38,
  "nextPage": 40,
  "slideType": "appendix_disclosure",
  "function": "other",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/39",
  "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5",
  "deckJsonHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5.json",
  "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-39",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Our intellectual property covering our innovative platform gene and gene-modified cell therapies in the US and abroad includes: Patents and patents applications for composition of matter and methods of use; Trade secrets/knowhow",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8402991-3db5-450b-bded-7cfe5f37360a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.8,
        "x": 0.1,
        "y": 0.33
      },
      "kind": "table",
      "text": "Renovaro Pipeline, Patent Title/Ownership, Link to Patent/Application No.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05a5a66a-129e-4aef-8134-0d6ba1cd48eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.07,
        "y": 0.05
      },
      "kind": "title",
      "text": "INTELLECTUAL PROPERTY",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ca4bb4c-e8a0-4e41-8db3-b190b34cd2b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 41,
      "from": 20,
      "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}